Kamala Harris

Joe Biden

Dean Phillips

Marianne Williamson

Donald Trump

Vivek Ramaswamy

Nikki Haley

Ron DeSantis

Cornel West

Robert F. Kennedy

2024 United States Presidential Election

COVID-19 has given rise to many variants in the last two years, but none have so far managed to evade the authorized vaccines that have been administered to millions around the world. Should that ever change, Pfizer and Moderna said they stand ready to act. 



CTV News

Canada

Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon

Pharmaceutical companies say they can respond quickly if B.1.1.529 found to be ‘escape variant’ 

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Independent

Evgeny Lebedev

London

Greater London

England

United Kingdom

Vaccine firms work to tweak jabs against new ‘omicron’ Covid variant

BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. Meanwhile, Moderna Inc said in a statement it is working to advance a booster candidate tailored to the new variant.

Bell Media

PFIZER and Moderna are reportedly capable of updating their COVID-19 vaccines as the new Omicron strain has sparked fear across the world.

Daily Express

Reach plc

Pfizer and Moderna can update COVID-19 vaccines to fight new Omicron Covid variant

Pharmaceutical firms are tweaking their existing Covid vaccines amid fears the Omicron strain could render them less effective (Picture: Reuters; Getty)Pharmaceutical firms are racing against the clock to adapt their Covid vaccines after the emergence of highly infectious new variant, Omicron.The strain has been designated a ‘variant of concern’ by the World Health Organisation amid warnings it could spread more rapidly than others.Health Secret…

Metro News

Alfred Harmsworth (barrister)

Geraldine Mary Harmsworth

Patricia Harmsworth, Viscountess Rothermere

Race against the clock to adapt Covid vaccines over new Omicron variant

Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest. 

CNBC

Roberts family

United States

Vaccine makers move quickly against new omicron Covid variant, testing already under way

Drugmaker said it could develop a vaccine for the Omicron variant in 100 days, but government clearance could take longer.

CBS News

National Amusements

Michael Redstone

Pfizer testing its vaccine against new COVID-19 strain

Work is under way to tweak vaccines against the new concerning strain of coronavirus that has sparked travel bans.

Shropshire Star

MNA Media

Ketley

Shropshire

Pharmaceutical firms work to tweak vaccines against new ‘Omicron’ variant

Health Secretary Sajid Javid said there is “huge international concern” about the strain.

Evening Standard

Carron Greig

BioNTech, AstraZeneca, and Johnson & Johnson have announced plans to test their vaccinations against the new variant of concern.

Newsweek

IBT Media

Omicron variant prompts concerns about vaccine efficacy as scientists race to test strain

World economies were slowly and gradually opening borders after facing the wrath of the coronavirus (COVID-19) pandemic in the past two years. But a new variant with a large number of mutations poses a bigger threat to the world. After the initial examination, the scientists have said that the new variant is the most worrying Covid variant since delta. 

WION

Invesco

Noida

Uttar Pradesh

India

COVID-19: Will vaccines work against the Omicron variant? Here's what experts say

Moderna

Vaccinations

International

Pfizer

North America

Health

Vaccines

Coronavirus

Washington DC

Washington

District of Columbia

Sky News UK

Press & Journal

Business Insider

Anadolu Ajansı

Express & Star

Latestly

Political Wire

The Gateway Pundit

MarketWatch

India TV News

Mediaite

Financial Times

Fox Business

Freedom Rock Radio

Blackpool Gazette

Breaking News

Fox 6 now

Euro Weekly News

GB News

The Global Herald

Helsinki Times

Q13 Fox

upday

Thai Newsroom

Biziday

The Guardian

Big News Network

MCUTimes

Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain

Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics